logo
adjaye associates unveils rammed earth children's cancer research centre for ghana

adjaye associates unveils rammed earth children's cancer research centre for ghana

Business Mayor21-05-2025

The design for an International Children's Cancer Research Centre, recently unveiled by Adjaye Associates, begins with the land. Set to perch along the eastern slopes of the Atewa Range in Kyebi, Ghana, the proposed ICCRC is grounded in its setting before it rises in form. From the approach, the landscape of dense forests and filtered sunlight sets the tone. It is this atmosphere of continuity that guides the healthcare facility's masterplan, which holds the promise of both care and research for West Africa's youngest cancer patients.
The center is designed as a holistic campus for the Wish4Life Foundation. Adjaye Associates organizes the 225,000-square-meter site into a network of buildings that hold more than function. Each structure — hospital, research lab, training institute, family residence, and chapel — participates in a larger rhythm of movement and repose. The spaces are open to the air and shaded from the sun, responding to the region's climate as well as its cultural logics. The unimposing architecture settles into the terrain with a clarity that seeks to invite trust.
visualizations © Adjaye Associates adjaye associates draws from Akan Traditions
With the International Children's Cancer Research Centre, the architects at Adjaye Associates draw from the Akan worldview. This proposes that illness results from a disturbance of personal, communal, and environmental harmony. Courtyards shaped like the Fihankra, or traditional compound, organize the campus into nested zones of rest and interaction. These enclosures hold the cadence of daily life, offering open-air rooms for conversation, reflection, and retreat. In Adjaye Associates' design, care is inseparable from architecture.
The complex will be built from earth — rammed, pressed, and baked into slabs and bricks. Timber and clay, shaped by local hands, bring continuity between building and community. The Welcome Centre greets patients and families with the soft tactility of earth walls, while concrete screens in clinical zones reference Kente cloth, a gesture to ancestral pattern and meaning. Each material carries its own history into the future.
Adjaye Associates unveils a cancer research center as a new model for pediatric care in Ghana A new precedent for a Cancer Research Centre
Adjaye Associates follows a low-energy design ethos with its International Children's Cancer Research Centre. The team employs passive cooling techniques, photovoltaic systems, and orientation strategies specific to the site. These decisions are embedded in the architecture, not appended to it, forming an infrastructure of resilience. The goal is to create a self-sustaining facility that can adapt to environmental change while maintaining a high standard of care.
Here, a different model for pediatric healthcare is proposed. It refuses the imported template of compartmentalized buildings and anonymous corridors. Instead, it cultivates a campus in which care, learning, worship, and research support one another in spatial continuity. This vision expands the definition of a hospital, suggesting that architecture itself can foster dignity, belonging, and healing.
A presentation of the proposal is currently exhibited at the Time Space Existence show during the 2025 Venice Architecture Biennale. It will be housed in Palazzo Bembo through November, and places Ghana on an international stage.
the ICCRC is sited on the forested slopes of the Atewa Range in Kyebi Read More The Zillow App Will Now Show a Home's Climate Risks
the campus integrates clinical research, educational, and residential functions into one connected whole
materials such as rammed earth, brick, and timber are locally-sourced and crafted by local builders

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

KFSHRC First in the Middle East to Implant AI-Powered Brain-Sensing Device for Treating Neurological Disorders
KFSHRC First in the Middle East to Implant AI-Powered Brain-Sensing Device for Treating Neurological Disorders

Yahoo

time10 hours ago

  • Yahoo

KFSHRC First in the Middle East to Implant AI-Powered Brain-Sensing Device for Treating Neurological Disorders

RIYADH, Saudi Arabia, June 11, 2025 (GLOBE NEWSWIRE) -- In a landmark medical achievement, King Faisal Specialist Hospital & Research Centre (KFSHRC) has become the first institution in the Middle East to successfully implant an AI-powered brain-sensing device designed for the treatment of complex neurological disorders. The breakthrough ushers in a new era of real-time, adaptive neuromodulation therapy, offering renewed hope for patients suffering from Parkinson's disease, epilepsy, and other movement disorders. The device utilizes artificial intelligence to continuously monitor the brain's electrical activity, identifying abnormal neural signals and delivering precisely targeted electrical impulses to restore neurological balance. Powered by a closed-loop system, the device automatically adjusts stimulation in real time based on the patient's brain activity, enabling highly responsive, personalized therapy and consistent symptom control throughout the day. The minimally invasive procedure, typically completed within three to five hours, has shown the potential to reduce patients' reliance on medication by as much as 50%. This cuts down detrimental side effects and enhances patients' autonomy and quality of life. Initial outcomes suggest rapid post-operative recovery and tangible improvements in symptom control within weeks. This breakthrough reflects the leadership and clinical excellence of KFSHRC's Neuroscience Centre of Excellence, which provides comprehensive, multidisciplinary care for adult and paediatric neurological cases. The Center leads the region in deep brain stimulation (DBS) for movement disorders, stereotactic EEG for epilepsy, and AI-based diagnostics for cognitive conditions and autism. Through continuous innovation and a patient-centred approach, it is redefining regional standards in neuroscience and setting new benchmarks in precision brain health. It is noteworthy that KFSHRC has been ranked first in the Middle East and Africa and 15th globally in the list of the world's top 250 Academic Medical Centres for the third consecutive year and recognised as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2025 Brand Finance rankings. Additionally, it was included in the World's Best Smart Hospitals list for 2025 by Newsweek magazine. For more information, visit or contact our media team at mediacoverage@ A photo accompanying this announcement is available at

KFSHRC Pioneering Clinical Trials and Gene Therapy Across the Region
KFSHRC Pioneering Clinical Trials and Gene Therapy Across the Region

Business Upturn

time04-06-2025

  • Business Upturn

KFSHRC Pioneering Clinical Trials and Gene Therapy Across the Region

RIYADH, Saudi Arabia, June 04, 2025 (GLOBE NEWSWIRE) — As part of Saudi Arabia's broader biotechnology transformation under Vision 2030, King Faisal Specialist Hospital & Research Centre (KFSHRC) solidified its role as the Kingdom's leading Clinical Trials hub in 2024 — conducting 52.4% of all active Clinical Trials nationwide, according to the Saudi National Institute of Health. This milestone reflects the sustained success of KFSHRC's Clinical Trials Transformation Initiative, launched in 2021 to build an integrated, patient-centered research ecosystem. By the end of 2024, the hospital had recorded 701 active research proposals, representing an 8% increase over the previous year. In Riyadh alone, research approvals rose by 20%, demonstrating growing alignment between scientific discovery and clinical care delivery. KFSHRC's research growth was matched by key innovation milestones. In 2024, it became the first in Saudi Arabia to locally produce CAR-T cells — a major step toward national self-sufficiency in advanced therapies. It also delivered a breakthrough in hemophilia care, using one-time gene therapy to restore clotting function in eight patients, eliminating preventive treatment and significantly improving quality of life. These advancements align closely with Saudi Arabia's Vision 2030 and National Biotechnology Strategy, which designate biotechnology as a national priority sector — aiming to localize therapeutic development, accelerate innovation, and establish global leadership by 2040. Complementing its scientific leadership, KFSHRC has also invested in public engagement, launching awareness campaigns in high-traffic public venues to promote Clinical Trials literacy and reduce misconceptions around participation. It is noteworthy that KFSHRC has been ranked first in the Middle East and Africa and 15th globally among the world's top 250 Academic Medical Centres for the third consecutive year, and recognised as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2025 Brand Finance rankings. Additionally, it was included in the World's Best Smart Hospitals list for 2025 by Newsweek magazine. For more information, visit or contact our media team at [email protected]. A photo accompanying this announcement is available at Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.

KFSHRC Pioneering Clinical Trials and Gene Therapy Across the Region
KFSHRC Pioneering Clinical Trials and Gene Therapy Across the Region

Yahoo

time04-06-2025

  • Yahoo

KFSHRC Pioneering Clinical Trials and Gene Therapy Across the Region

KFSHRC accounts for 52.4% of all active clinical trials in Saudi Arabia. RIYADH, Saudi Arabia, June 04, 2025 (GLOBE NEWSWIRE) -- As part of Saudi Arabia's broader biotechnology transformation under Vision 2030, King Faisal Specialist Hospital & Research Centre (KFSHRC) solidified its role as the Kingdom's leading Clinical Trials hub in 2024 — conducting 52.4% of all active Clinical Trials nationwide, according to the Saudi National Institute of Health. This milestone reflects the sustained success of KFSHRC's Clinical Trials Transformation Initiative, launched in 2021 to build an integrated, patient-centered research ecosystem. By the end of 2024, the hospital had recorded 701 active research proposals, representing an 8% increase over the previous year. In Riyadh alone, research approvals rose by 20%, demonstrating growing alignment between scientific discovery and clinical care delivery. KFSHRC's research growth was matched by key innovation milestones. In 2024, it became the first in Saudi Arabia to locally produce CAR-T cells — a major step toward national self-sufficiency in advanced therapies. It also delivered a breakthrough in hemophilia care, using one-time gene therapy to restore clotting function in eight patients, eliminating preventive treatment and significantly improving quality of life. These advancements align closely with Saudi Arabia's Vision 2030 and National Biotechnology Strategy, which designate biotechnology as a national priority sector — aiming to localize therapeutic development, accelerate innovation, and establish global leadership by 2040. Complementing its scientific leadership, KFSHRC has also invested in public engagement, launching awareness campaigns in high-traffic public venues to promote Clinical Trials literacy and reduce misconceptions around participation. It is noteworthy that KFSHRC has been ranked first in the Middle East and Africa and 15th globally among the world's top 250 Academic Medical Centres for the third consecutive year, and recognised as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2025 Brand Finance rankings. Additionally, it was included in the World's Best Smart Hospitals list for 2025 by Newsweek magazine. For more information, visit or contact our media team at mediacoverage@ A photo accompanying this announcement is available at

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store